What is the recommended management approach for an elderly patient with hypertension, proteinuria, fluctuating and accelerated blood pressure, who is compliant on multiple antihypertensive agents and has a normal renal Doppler ultrasound?

Management Approach for Resistant Hypertension in Elderly Patient with Proteinuria

Add spironolactone as the fourth antihypertensive agent if not already prescribed, as this is the guideline-recommended next step for resistant hypertension on triple therapy, and refer to a hypertension specialist for evaluation of secondary causes beyond renovascular disease. 1

Immediate Medication Optimization

Since this elderly patient is compliant on multiple antihypertensives with fluctuating and accelerated BP despite normal renal Doppler, you are dealing with resistant hypertension requiring systematic escalation:

Step 1: Verify Current Regimen Adequacy

• Ensure the patient is on full-dose triple therapy: ACE inhibitor/ARB + dihydropyridine calcium channel blocker + thiazide-like diuretic (chlorthalidone or indapamide preferred over hydrochlorothiazide) 1, 2
• Confirm once-daily dosing with single-pill combinations to maximize adherence 1
• The presence of proteinuria makes ACE inhibitor or ARB mandatory as first-line therapy 3, 4

Step 2: Add Fourth-Line Agent

Add spironolactone 25-50 mg daily as the evidence-based fourth agent for resistant hypertension 1, 2. This is superior to other fourth-line options and specifically recommended by ISH 2020 and ESC 2024 guidelines.

• If spironolactone is contraindicated or not tolerated, alternatives in order of preference: eplerenone, amiloride, doxazosin, clonidine, or beta-blocker 1
• Monitor potassium and renal function closely when adding mineralocorticoid receptor antagonists

Blood Pressure Targets in This Elderly Patient

Target BP should be individualized to 130-140/70-80 mmHg based on frailty status 1:

• If fit and independent: aim for <130/80 mmHg 2
• If mildly frail or >80 years: aim for <140/90 mmHg 1
• Never reduce diastolic BP below 60 mmHg in elderly patients regardless of systolic target 5
• The proteinuria indicates target organ damage, making this a high-risk patient who benefits from tighter control if tolerated 3, 4

Critical Pitfall: BP Measurement Technique

The "fluctuation in BP" raises concern for pseudoresistance due to measurement error:

• Use validated automated upper arm cuff with appropriate cuff size 1
• Confirm hypertension with home BP monitoring (target <135/85 mmHg) or 24-hour ambulatory monitoring (target <130/80 mmHg) 1, 2
• Average multiple readings—guidelines recommend averaging up to 20 office readings for diagnosis 1
• Measure BP in both arms; use the arm with higher readings consistently 1

Evaluation for Secondary Hypertension

Despite normal renal Doppler, refer to hypertension specialist for evaluation of other secondary causes 1:

Key Secondary Causes to Exclude:

• Primary aldosteronism: Most common secondary cause in resistant hypertension; check aldosterone-to-renin ratio
• Obstructive sleep apnea: Common in elderly with resistant hypertension; consider screening questionnaire
• Medication/substance interference: NSAIDs, decongestants, licorice, excessive alcohol
• Non-adherence verification: Despite reported compliance, consider witnessed dosing or pill counts

The normal renal Doppler effectively rules out hemodynamically significant renovascular disease, which is appropriate given the clinical presentation 6.

Proteinuria Management

The proteinuria requires specific attention:

• Quantify proteinuria: Obtain urine albumin-to-creatinine ratio (UACR) or protein-to-creatinine ratio (UPCR); UACR is preferred for risk stratification 7
• Maximize RAS blockade: Ensure full-dose ACE inhibitor or ARB 3, 4
• **Target BP <130/80 mmHg** if proteinuria is significant (>500 mg/24hr or UACR >30 mg/mmol) and patient is not frail 3, 8
• Consider adding SGLT2 inhibitor if eGFR ≥20 mL/min/1.73 m² for additional renoprotection 8

Timeline and Monitoring

• Achieve target BP within 3 months to maintain patient confidence and reduce cardiovascular risk 1, 2
• After adding spironolactone, recheck BP in 2-4 weeks
• Monitor potassium and creatinine 1-2 weeks after starting spironolactone
• If BP remains uncontrolled after optimizing four-drug therapy, specialist referral is mandatory 1

Common Pitfalls to Avoid

1. Don't assume compliance without verification—even "compliant" patients may have issues with timing, technique, or understanding
2. Don't use combination ACE inhibitor + ARB—this is contraindicated and increases harm without benefit 2
3. Don't ignore frailty assessment—overly aggressive BP lowering in frail elderly increases falls, syncope, and mortality 1, 5, 9
4. Don't accept office BP alone—confirm with out-of-office monitoring to avoid white coat effect 1, 2